Literature DB >> 2320391

Molecular forms of lactoferrin in stool and urine from infants fed human milk.

A S Goldman1, C Garza, R J Schanler, R M Goldblum.   

Abstract

The molecular forms of lactoferrin (LF) were examined in stools and urine collected at 2.5 or 5 wk of age from very low birth wt infants fed either a cow's milk formula or a fortified human milk preparation. LF was not found by Western blotting in excreta from infants fed cow's milk. In contrast, intact and fragmented forms of LF were detected in stools and concentrated urine of each infant who received human milk. Only intact LF was detected in the fortified human milk preparation, whereas many types of LF fragments were present in the stools and urine. The approximate molecular wt of the most prominent fragments were 44, 38, 34, and 32 kD. However, the stools also displayed lower molecular wt fragments that were not found in urines of those infants. The LF fragments in those excreta were similar in size to those produced in vitro by limited digestion of apo-LF with trypsin. Furthermore, fragments produced by in vitro proteolysis were immunoreactive in an ELISA for LF. Thus, the fragments of LF in stools of very low birth wt infants fed human milk appeared to be produced by in vivo proteolysis, and the close resemblance between the LF fragments in the stools and urine suggests that the urinary LF fragments originated in the gastrointestinal tract. It remains unclear, however, whether the whole LF molecules that were fragmented were derived solely from ingested LF in human milk or in part from LF produced by the infant in response to human milk feedings.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320391     DOI: 10.1203/00006450-199003000-00009

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Diane Dryja; Allen Leavens; Ronald L Neiswander; Haiping Qiao; Douglas DiRienzo; Pearay Ogra
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 2.  Biological role of lactoferrin.

Authors:  L Sánchez; M Calvo; J H Brock
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

3.  Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.

Authors:  L A Håversen; I Engberg; L Baltzer; G Dolphin; L A Hanson; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation.

Authors:  T W Hutchens; J F Henry; T T Yip
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 5.  Current peptidomics: applications, purification, identification, quantification, and functional analysis.

Authors:  David C Dallas; Andres Guerrero; Evan A Parker; Randall C Robinson; Junai Gan; J Bruce German; Daniela Barile; Carlito B Lebrilla
Journal:  Proteomics       Date:  2015-01-21       Impact factor: 3.984

6.  N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.

Authors:  P H van Berkel; M E Geerts; H A van Veen; M Mericskay; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  Evolution of the mammary gland defense system and the ontogeny of the immune system.

Authors:  Armond S Goldman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 8.  Growth hormone and prolactin--molecular and functional evolution.

Authors:  Isabel A Forsyth; Michael Wallis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

9.  Milk Peptides Survive In Vivo Gastrointestinal Digestion and Are Excreted in the Stool of Infants.

Authors:  Robert L Beverly; Robert K Huston; Andi M Markell; Elizabeth A McCulley; Rachel L Martin; David C Dallas
Journal:  J Nutr       Date:  2020-04-01       Impact factor: 4.798

10.  Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding.

Authors:  Sandrine Moussa; Mohammad-Ali Jenabian; Jean Chrysostome Gody; Josiane Léal; Gérard Grésenguet; Alain Le Faou; Laurent Bélec
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.